Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2631

PDF: 1361
New approved drugs for psoriatic arthritis

F.M. Perrotta, E. Lubrano

57-64

09-09-2016

https://doi.org/10.4081/reumatismo.2016.873

3113

PDF: 2194
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

143-166

31-10-2013

https://doi.org/10.4081/reumatismo.2013.143

7043

PDF: 2521
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini

45-56

16-09-2015

https://doi.org/10.4081/reumatismo.2015.811

2181

PDF: 1087
Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

224-232

06-11-2014

https://doi.org/10.4081/reumatismo.2014.748

2300

PDF: 1547
How much does an antiinflammatory treatment cost?

D. Gatti, O. Viapiana, G. Colombo, S. Adami

248-252

https://doi.org/10.4081/reumatismo.2010.248

1238

PDF: 647
Intra-articular therapy with tumor necrosis factor-α antagonists: an update

S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

257-263

14-03-2014

https://doi.org/10.4081/reumatismo.2013.721

2546

PDF: 1210
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

54-64

https://doi.org/10.4081/reumatismo.2009.54

1239

PDF: 1039
Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

57-61

16-09-2015

https://doi.org/10.4081/reumatismo.2015.823

2152

PDF: 1029
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

07-04-2025

https://doi.org/10.4081/reumatismo.2025.1817

1143

PDF: 315

SUPPLEMENTARY MATERIAL: 174
Safety of lornoxicam in G-6-PDH deficiency

G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero

45-47

https://doi.org/10.4081/reumatismo.2003.45

759

PDF: 554
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

29-01-2025

https://doi.org/10.4081/reumatismo.2025.1754

1101

PDF: 25

SUPPLEMENTARY MATERIAL: 90
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1602

1789

PDF: 430
Italian Society of Rheumatology recommendations for the management of gout

M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

4-21

28-03-2013

https://doi.org/10.4081/reumatismo.2013.4

5695

PDF: 1513
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3723

PDF: 2400
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

29-12-2022

https://doi.org/10.4081/reumatismo.2022.1511

1861

PDF: 784
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

285-303

31-03-2015

https://doi.org/10.4081/reumatismo.2014.799

2496

PDF: 2247
Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

224-235

https://doi.org/10.4081/reumatismo.2003.224

1108

PDF: 2505
Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

32-37

https://doi.org/10.4081/reumatismo.2007.32

1638

PDF: 739
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1159

PDF: 773
The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

L. Riente

74-79

https://doi.org/10.4081/reumatismo.2004.1s.74

744

PDF: 887
Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

46-50

https://doi.org/10.4081/reumatismo.2010.46

1085

PDF: 1306
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

623

PDF: 558
Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

145-150

https://doi.org/10.4081/reumatismo.2001.145

989

PDF: 701
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

22-01-2025

https://doi.org/10.4081/reumatismo.2025.1744

1081

PDF: 17

SUPPLEMENTARY MATERIAL: 4
Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

299-303

https://doi.org/10.4081/reumatismo.2007.299

907

PDF: 710
Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases

R. Deniz, N. Güner, Ş.A. Ekmen, İ.N. Mutlu, D.S. Özgür, B. Karaalioğlu, G. Akkuzu, F. Yıldırım, K. Kalkan, G. Güzelant-Özköse, B. İnce, M. Erdoğan, Y. Özlük, I. Kılıçaslan, C. Bes

18-09-2023

https://doi.org/10.4081/reumatismo.2023.1586

1259

PDF: 516
Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

M. Arreghini, P. Prudente, W. Maglione, C. Arnoldi, S. Tosi, A. Marchesoni

140-144

https://doi.org/10.4081/reumatismo.2001.140

811

PDF: 1142
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

244-261

https://doi.org/10.4081/reumatismo.2007.244

1288

PDF: 1104
Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

104-109

https://doi.org/10.4081/reumatismo.2004.104

1214

PDF: 1012
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

34-39

https://doi.org/10.4081/reumatismo.2005.4s.34

1130

PDF: 1125
Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

209-214

https://doi.org/10.4081/reumatismo.2007.209

895

PDF: 1024
Treatment of Wegener’s granulomatosis

V. Riccieri, G. Valesini

69-76

https://doi.org/10.4081/reumatismo.2004.69

1316

PDF: 5188
Current therapeutic strategies for HCV-associated cryoglobulinemia

F. Iannuzzella, G. Garini

163-173

https://doi.org/10.4081/reumatismo.2008.163

1029

PDF: 2001
Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

267-272

https://doi.org/10.4081/reumatismo.2005.267

1050

PDF: 1658
Psoriasis in women with psoriatic arthritis: hormonal effects, fertility, and considerations for management at different stages of life

F. Cassalia, A. Belloni Fortina

11-09-2024

https://doi.org/10.4081/reumatismo.2024.1775

2233

PDF: 889
Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome

N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita

202-208

https://doi.org/10.4081/reumatismo.2007.202

1397

PDF: 1242
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

M.G. Portuesi, P. Perosa

61-63

https://doi.org/10.4081/reumatismo.2008.61

1153

PDF: 862
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

93-102

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1235

897

PDF: 573
Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren’s syndrome (SS) not responding to standard treatment with artificial tears

P. Ostuni, M.E.C. Battista, A. Furlan

119-124

https://doi.org/10.4081/reumatismo.2005.119

969

PDF: 2022
Safety of rituximab in rheumatoid arthritis

M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

101-106

https://doi.org/10.4081/reumatismo.2010.101

1650

PDF: 992
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1608

1464

PDF: 534
The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis

S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè

22-49

23-09-2019

https://doi.org/10.4081/reumatismo.2019.1202

7870

PDF: 2358
A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib

F.M. Mariani, A. Alunno, F. Carubbi, C. Ferri

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1620

1371

PDF: 468
TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

275-282

https://doi.org/10.4081/reumatismo.2006.275

1021

PDF: 929
Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis

G.P. Pasero, O. Di Munno

238-242

https://doi.org/10.4081/reumatismo.2002.238

3822
IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

62-73

https://doi.org/10.4081/reumatismo.2004.1s.62

1267

PDF: 1907
Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

268-274

https://doi.org/10.4081/reumatismo.2006.268

1532

PDF: 2662
The treatment of recurrent uveitis with TNFα inhibitors

P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

185-189

https://doi.org/10.4081/reumatismo.2004.185

1729

PDF: 2354
Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis

K.V. Ilic, M. Sefik-Bukilica, S. Jankovic, N. Vujasinovic-Stupar

27-33

https://doi.org/10.4081/reumatismo.2009.27

1485

PDF: 1105

1 - 50 of 54 items 1 2 > >>

Search

Search Results

authors

reviewers

Categories

indexing

Keywords